Pharming Group (OTCMKTS:PHGUF) Shares Down 0.9% - What's Next?

Key Points

• Pharming Group (OTCMKTS:PHGUF) shares decreased by 0.9%, trading at $1.14 during mid-day on Monday.
• The company has a market capitalization of $765.02 million and a negative price-to-earnings ratio of -114.00.
• Pharming specializes in protein replacement therapies and offers treatments for rare diseases, including RUCONEST for hereditary angioedema.

Pharming Group NV (OTCMKTS:PHGUF - ) dropped 0.9% during mid-day trading on Monday . The stock traded as low as $1.14 and last traded at $1.14. Approximately 5,000 shares traded hands during mid-day trading, The stock had previously closed at $1.15.

Pharming Group Trading Down 0.9%

The firm has a market cap of $765.02 million, a price-to-earnings ratio of -114.00 and a beta of 0.65. The company has a quick ratio of 2.00, a current ratio of 2.76 and a debt-to-equity ratio of 0.51. The business has a 50 day moving average price of $1.13 and a 200-day moving average price of $0.98.

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.